Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||
| Net Income | -694 | -1,050 |
| Depreciation Amortization | 150 | 568 |
| Accounts payable and accrued liabilities | 576 | N/A |
| Other Working Capital | 559 | 129 |
| Other Operating Activity | -576 | 0 |
| Operating Cash Flow | $15 | $-353 |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $N/A | $0 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | -353 | 717 |
| Financing Cash Flow | $-353 | $717 |
| Beginning Cash Position | 437 | 73 |
| End Cash Position | 99 | 437 |
| Net Cash Flow | $-338 | $364 |
| Free Cash Flow | ||
| Operating Cash Flow | 15 | -353 |
| Free Cash Flow | 15 | -353 |